Six days after the US FDA approved GlaxoSmithKline PLC’s Krintafel (tafenoquine) for prevention of malaria relapse, an advisory committee will consider [60 Degrees Pharmaceuticals LLC]’s application for the same compound for malaria prophylaxis.
However, the prophylactic indication and extended dosing regimen with 60 Degrees’ tafenoquine (TQ) formulation could raise more safety concerns for...





